Washington (AP) — President Joe Biden’s plan to begin delivering booster shots by September 20 to most COVID-19 vaccinated Americans is the third time for Moderna vaccinated people. We are facing new complications that may delay the availability of vaccinations. Authorities said on Friday.
Biden awaited approval from the US Centers for Disease Control and Prevention and the Food and Drug Administration last month to make boosters available to all mRNA-vaccinated Americans to provide more lasting protection against the coronavirus. Announced that it plans to do. ..
However, these agencies are waiting for important data before approving a third dose, and it is increasingly seen that Moderna’s vaccine is unlikely to reach the September 20 milestone.
According to one source, Moderna created insufficient data for the FDA and CDC to recommend a third dose of the vaccine, and the FDA requested additional data that could delay these boosters in October. bottom. Pfizer, which is in the process of reviewing further, will be approved for a third dose by September 20, with data collected from the use of the vaccine in Israel. The FDA’s main panel is to review Pfizer’s data. At the booster on September 17th.
Data on boost immunization of Johnson & Johnson’s single-dose vaccine will not be available for several months because the injection was not approved until February, officials said.
FDA Deputy Commissioner Dr. Janet Woodcock and CDC Director Dr. Rochelle Warrensky told White House COVID-19 coordinator Jeff Seientz and other officials about the expected delay in Modana on Thursday. The official said he explained.
According to CDC data, most of the 206 million Americans who were vaccinated with COVID-19 at least partially were vaccinated against Pfizer, while about 80 million were vaccinated against Modana. I did.
The government’s public announcement of booster availability was a departure from the more cautious and behind-the-scenes plans that defined early vaccination campaigns, raising concerns that the White House was ahead of booster science.
The White House is only preparing for final approval of the booster, and said the review is “part of the ongoing process.”
Chris Meeger, a White House spokesman, referred to the CDC’s Advisory Committee on Immunization and State, “waiting for full review and approval by the FDA and recommendations by the ACIP.” “When that approval and recommendation is made, we are ready to carry out a plan developed by the top doctors in our country so that we can be ahead of the virus.”
Even before Biden’s announcement last month, his administration was preparing for months in preparation for the need for boosters, maintaining US dose supply and bringing it to the first vaccination campaign. Biden told reporters Thursday that he had devised a promotion plan with the same “strength” as.
On August 18, Biden touted the booster as protection against the more contagious delta variants of the virus, which raged nationwide and slowed economic recovery from the pandemic.
“As a simple rule, rule: don’t forget to get a booster shot eight months after the second shot,” he said, and health professionals awaited regulatory approval on September 20. He added that he was aiming to be ready to manage them by. agency.
Dr. Anthony Fauci, a top US infectious disease expert, has become a candid champion of the booster campaign as the Biden administration seeks to reduce delta variants.
He told reporters Thursday that he believed that all Americans would need to be vaccinated with a third mRNA vaccine in order to be considered fully vaccinated against COVID-19.
“From my own experience as an immunologist, I wouldn’t be surprised at all that a proper and complete regimen for vaccination would probably be three doses,” he said.
The formal decision that a “full vaccination” requires a third vaccination has widespread implications for schools, businesses, and other organizations implementing vaccination obligations.
The US booster program faces complexity and some may miss September 20 | National News
Source link The US booster program faces complexity and some may miss September 20 | National News